We are live on
!
Find out more
Crinetics Pharmaceuticals
CRNX
CRNX
225 hedge funds and large institutions have $4.49B invested in Crinetics Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 86 increasing their positions, 73 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 35
2.69% more ownership
Funds ownership: 111.68% → 114.37% (+2.7%)
1% more funds holding
Funds holding: 222 → 225 (+3)
Holders
225
Holding in Top 10
8
Calls
$45.9M
Puts
$8.9M
Top Buyers
| 1 | +$82.3M | |
| 2 | +$35.9M | |
| 3 | +$29.6M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$14.3M |
| 5 |
RI
RTW Investments
New York
|
+$13M |
Top Sellers
| 1 | -$32.5M | |
| 2 | -$24M | |
| 3 | -$21M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$20.1M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$12.3M |